Outset Medical (NASDAQ:OM) Given Sector Perform Rating at Royal Bank Of Canada

Royal Bank Of Canada reaffirmed their sector perform rating on shares of Outset Medical (NASDAQ:OM) in a research report released on Tuesday morning,Benzinga reports. They currently have a $22.00 price objective on the stock.

Several other research firms have also recently issued reports on OM. Scotiabank raised shares of Outset Medical to a “strong-buy” rating in a research report on Thursday, May 15th. Wall Street Zen raised Outset Medical from a “sell” rating to a “hold” rating in a report on Saturday, June 7th. Finally, BTIG Research set a $37.00 price objective on Outset Medical and gave the company a “buy” rating in a report on Monday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Outset Medical has an average rating of “Buy” and a consensus price target of $24.67.

Outset Medical Stock Down 2.3%

Shares of Outset Medical stock opened at $13.35 on Tuesday. The company has a quick ratio of 6.05, a current ratio of 7.47 and a debt-to-equity ratio of 0.63. Outset Medical has a 52-week low of $5.85 and a 52-week high of $25.35. The company has a market capitalization of $237.18 million, a P/E ratio of -0.66 and a beta of 2.14. The company has a 50 day moving average of $17.68 and a 200 day moving average of $14.59.

Institutional Investors Weigh In On Outset Medical

Institutional investors have recently bought and sold shares of the business. Legal & General Group Plc acquired a new position in shares of Outset Medical during the 2nd quarter valued at $34,000. Ameritas Investment Partners Inc. purchased a new position in Outset Medical in the second quarter valued at about $35,000. BNP Paribas Financial Markets lifted its stake in shares of Outset Medical by 7,013.8% during the second quarter. BNP Paribas Financial Markets now owns 2,063 shares of the company’s stock worth $40,000 after purchasing an additional 2,034 shares in the last quarter. Police & Firemen s Retirement System of New Jersey purchased a new stake in shares of Outset Medical in the second quarter worth about $78,000. Finally, New York State Common Retirement Fund acquired a new stake in shares of Outset Medical in the second quarter valued at about $108,000.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.